VolitionRx-led Consortium Awarded $1M Eurostars Grant
September 03, 2013 at 06:45 AM EDT
VolitionRx Limited (OTC: VNRX ), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, is lead partner of a consortium in a project valued at €779,493 (approx. US$1M) under the EUREKA Eurostars scheme. The project aims to develop new applications of the Nucleosomics
